Generali Investments CEE investicni spolecnost a.s. Acquires New Stake in Exelon Co. (NASDAQ:EXC)

Generali Investments CEE investicni spolecnost a.s. acquired a new stake in Exelon Co. (NASDAQ:EXC) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,600 shares of the company’s stock, valued at approximately $1,189,000.

A number of other institutional investors and hedge funds have also bought and sold shares of EXC. Czech National Bank grew its holdings in Exelon by 7.0% during the 4th quarter. Czech National Bank now owns 217,868 shares of the company’s stock worth $8,201,000 after acquiring an additional 14,158 shares during the period. Robeco Institutional Asset Management B.V. grew its holdings in Exelon by 20.8% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 1,624,805 shares of the company’s stock worth $61,158,000 after acquiring an additional 279,827 shares during the period. HITE Hedge Asset Management LLC grew its holdings in Exelon by 431.3% during the 3rd quarter. HITE Hedge Asset Management LLC now owns 395,840 shares of the company’s stock worth $16,051,000 after acquiring an additional 321,333 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Exelon by 2.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 6,446,408 shares of the company’s stock worth $261,402,000 after acquiring an additional 123,466 shares during the period. Finally, State Street Corp grew its holdings in Exelon by 3.7% during the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company’s stock worth $2,439,862,000 after acquiring an additional 2,156,259 shares during the period. 80.92% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Exelon

In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of Exelon stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the transaction, the executive vice president now owns 2,271 shares of the company’s stock, valued at $92,134.47. This trade represents a 39.18 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.10% of the stock is owned by insiders.

Exelon Price Performance

Shares of NASDAQ EXC opened at $43.11 on Friday. Exelon Co. has a fifty-two week low of $34.01 and a fifty-two week high of $45.19. The stock has a market cap of $43.33 billion, a price-to-earnings ratio of 17.60, a PEG ratio of 2.86 and a beta of 0.51. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.78 and a current ratio of 0.87. The firm’s 50-day simple moving average is $40.74 and its 200 day simple moving average is $39.54.

Exelon (NASDAQ:EXC) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same period in the previous year, the business posted $0.60 EPS. As a group, research analysts anticipate that Exelon Co. will post 2.64 earnings per share for the current fiscal year.

Exelon Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be given a $0.40 dividend. This is a boost from Exelon’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Monday, February 24th. This represents a $1.60 annualized dividend and a yield of 3.71%. Exelon’s dividend payout ratio (DPR) is presently 65.31%.

Analyst Ratings Changes

EXC has been the subject of a number of recent analyst reports. Morgan Stanley decreased their price target on Exelon from $46.00 to $44.00 and set an “equal weight” rating for the company in a report on Friday, November 22nd. Barclays increased their price target on Exelon from $42.00 to $48.00 and gave the stock an “overweight” rating in a report on Tuesday, February 25th. BMO Capital Markets restated an “outperform” rating on shares of Exelon in a research note on Tuesday, February 4th. Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Scotiabank raised their target price on Exelon from $42.00 to $44.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $44.13.

Exelon Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.